- Oops!Something went wrong.Please try again later.
Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous
Ad hoc announcement pursuant to Art. 53 LR
Dublin, Ireland - 30 December 2021: Cosmo Pharmaceuticals N.V. (SIX: COPN) ('Cosmo') today announced that Ms. Hazel Winchester has been appointed to the position of Head of Investor Relations and will take up the position on the 10th of January, 2022.
About Cosmo Pharmaceuticals
End of ad hoc announcement
Cosmo Pharmaceuticals N.V.
Riverside 2, Sir John Rogerson's
Dublin 2 Dublin
+ 353 1 817 0370
SIX Swiss Exchange
EQS News ID:
End of Announcement
EQS News Service